THERAVANCE BIOPHARMA, INC. : Other Events (form 8-K)

          xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

 

 

 

FORM 8-K

 

 

 

Current Report Pursuant

to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event Reported): January 7, 2020

 

 

Share

© Acquiremedia - 2020